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1 |  INTRODUCTION
Visceral hypersensitivity is commonly observed in pa-
tients with gastrointestinal diseases, such as irritable bowel 
syndrome (IBS) and inflammatory bowel disease (IBD), 
and contributes to the perception of pain in those condi-
tions (Chang et al., 2000; Ritchie, 1973). In the periphery, 
distal terminals of sensory neurones transduce noxious 
stimuli to produce nociception and the sensation of pain 
(Grundy, Erickson, and Brierley 2019; Hockley, Smith, & 
Bulmer, 2018; St John Smith, 2018). However, a switch 
from acute to chronic pain and long-term hypersensitiv-
ity can occur due to persistent activation of sensory nerve 
endings in response to disease-driven changes in the bowel 
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Abstract
Galanin is a neuropeptide expressed by sensory neurones innervating the gastrointes-
tinal (GI) tract. Galanin displays inhibitory effects on vagal afferent signaling within 
the upper GI tract, and the goal of this study was to determine the actions of galanin 
on colonic spinal afferent function. Specifically, we sought to evaluate the effect of 
galanin on lumbar splanchnic nerve (LSN) mechanosensitivity to noxious distending 
pressures and the development of hypersensitivity in the presence of inflammatory 
stimuli and colitis. Using ex vivo electrophysiological recordings we show that gala-
nin produces a dose-dependent suppression of colonic LSN responses to mechanical 
stimuli and prevents the development of hypersensitivity to acutely administered in-
flammatory mediators. Using galanin receptor (GalR) agonists, we show that GalR1 
activation, but not GalR2/3 activation, suppresses mechanosensitivity. The effect of 
galanin on colonic afferent activity was not observed in tissue from mice with dextran 
sodium sulfate-induced colitis. We conclude that galanin has a marked suppressive 
effect on colonic mechanosensitivity at noxious distending pressures and prevents 
the acute development of mechanical hypersensitivity to inflammatory mediators, 
an effect not seen in the inflamed colon. These actions highlight a potential role for 
galanin in the regulation of mechanical nociception in the bowel and the therapeutic 
potential of targeting galaninergic signaling to treat visceral hypersensitivity.
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microenvironment (e.g., the production of inflammatory 
mediators), coupled with longer-term changes in the plas-
ticity of the sensory nerve endings and subsequent sensi-
tization of central pain processing pathways. Therefore, 
factors involved in the development and regulation of vis-
ceral hypersensitivity represent potential targets for thera-
peutic intervention. Early phase pharmacological treatment 
with antibiotics, corticosteroids, or immunomodulators has 
been shown to reduce inflammation and in some individ-
uals visceral pain. However, there is still a large subset of 
patients that still experience discomfort and pain suggest-
ing that visceral pain is discontinuous with the disease 
activity (Bernstein, 2014). The distal colon receives dual 
sensory innervation from afferent fibers running within the 
lumbar splanchnic nerve (LSN) and the pelvic nerve (PN) 
(Deiteren et al., 2015). Both nerves have been implicated 
in the processing of nociception from the colorectum, with 
the PN being identified as the predominant pathway for the 
signaling of pain in response to rectal distension in humans, 
and the LSN being identified as the predominant pathway 
for the signaling of pain in response to distension of the 
sigmoid and descending colon (Brierley, Jones, Gebhart, 
& Blackshaw, 2004; Hughes, Brierley, & Blackshaw, 2009; 
Ray & Neill, 1947). Therefore, the modulation of LSN and 
PN signaling from respective colonic and rectal regions 
have important implications in the treatment of chronic 
visceral pain in GI diseases, such as IBS and IBD (Brierley 
et al., 2004; Siri et al., 2019).
One method by which colorectal sensory nerves can be 
modulated is through local release of peptides, calcitonin 
gene-related peptide (CGRP) being a widely used marker for 
such peptidergic sensory nerves, or from nonneuronal cells 
within the GI tract (Lakhan & Kirchgessner, 2010). We have 
shown through single-cell RNA sequencing that the pep-
tide galanin is highly expressed in colonic sensory neurones 
that also express Trpv1, that is, putative nociceptors and 
GDNF family receptor alpha-3 (Gfrα3), that is, high-thresh-
old stretch-sensitive afferents, suggesting a potential role in 
the regulation of colonic nociception (Hockley et al., 2019). 
Galanin acts upon three receptors, GalR1, GalR2, and GalR3 
(Branchek, Smith, Gerald, & Walker, 2000; Branchek, Smith, 
& Walker, 1998), and single-cell RNA sequencing demon-
strates that GalR1 is the most highly expressed in colonic 
sensory neurones and that its expression, along with that of 
GalR2 receptors, is largely restricted to Trpv1-positive tho-
racolumbar DRG arising from the LSN, consistent with the 
hypothesis of a paracrine role for galanin in the regulation 
of sensory signaling from the bowel (Hockley et al., 2019). 
Furthermore, GalR1 is also expressed in a population of 
colonic sensory neurones expressing mechanosensitive ion 
channel Piezo2, suggesting galanin could modulate LSN ac-
tivity over a range of pressures. When activated by galanin, 
GalR1 predominantly signals through Gi, suggesting that 
the effects of galanin on colonic afferent signaling would be 
inhibitory (Branchek et al., 2000). Consistent with this hy-
pothesis, in the upper GI tract of mice and ferrets, galanin 
suppresses vagal afferent signaling through the activation of 
GalR1 receptors. Galanin has also been shown to have a stim-
ulatory effect on vagal afferents through the activation of its 
Gq-coupled GalR2 receptor, with GalR3 receptors having no 
clear functional contribution despite its expression in the rel-
evant ganglia (Page, Slattery, Brierley, Jacoby, & Blackshaw, 
2007; Page et al., 2005).
The role of galaninergic signaling in the colorectum is 
currently unclear and in this study we set out to determine 
the effect of galanin upon LSN mechanosensitivity due to 
the high expression of both galanin and its receptors in the 
relevant thoracolumbar sensory ganglia. Moreover, because 
single-cell RNA-sequencing data demonstrate coexpression 
of GalR1 with receptors for certain inflammatory mediators 
(e.g., bradykinin and 5-hydroxytryptamine) and ion channels 
such as Trpv1 that are modulated by inflammatory media-
tors (Hockley et al., 2019), we wanted to determine if gala-
nin could suppress mechanical hypersensitivity induced by 
inflammatory mediators and extend this to an in vivo model 
of acute colitis.
We find that galanin is expressed by putative nociceptors 
originating from the LSN and that it inhibits LSN mecha-
nosensitivity via GalR1. Inflammatory mediator-induced 
mechanical hypersensitivity is also abolished by galanin, but 
suppression of mechanical hypersensitivity is lost in LSN ob-
tained from mice with colitis.
2 |  MATERIALS AND METHODS
2.1 | Animals and ethical approval
C57BL/6J mice were used for all experiments. All proto-
cols were performed in accordance with the UK Animals 
(Scientific Procedures) Act 1986 Amendment Regulations 
2012 following ethical review by the University of Cambridge 
Animal Welfare and Ethical Review Body and under UK 
Home Office Project Licences 70/7705 and P7EBFC1B1. 
Mice were conventionally housed in groups of 4–5 of the 
same gender with nesting material and a red plastic shelter; 
the holding room was temperature controlled (21°C), and 
mice were on a normal 12 hr/light dark cycle with food and 
water available ad libitum.
2.2 | Ex vivo mouse LSN preparation and  
recording
Adult (8–18  weeks) C57BL/6J male and female mice 
(Envigo) were humanely killed by cervical dislocation and 
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exsanguination, and the distal colon (from the splenic flex-
ure to rectum) with associated LSN was removed. Colonic 
content was flushed with Krebs buffer and the colon tied 
to either end of a cannula, and perfused luminally (200 μl/
min) and serosally (7 ml/min) with carboxygenated (95% 
O2, 5% CO2) Krebs buffer, in mM: 124 NaCl, 4.8 KCl, 
1.3 NaH2PO4, 2.5 CaCl2, 1.2 MgSO4·7H2O, 11.1 glucose, 
and 25 NaHCO3; supplemented with indomethacin (3 μM, 
to suppress prostanoid synthesis), and nifedipine (10 μM) 
and atropine (10  μM) to block smooth muscle contrac-
tion as previously described (Hockley et al., 2014). The 
bath was maintained at 32°C–34°C. The inferior and su-
perior mesenteric ganglia were identified at the point of 
the iliac bifurcation and suction electrode recordings of 
multiunit activity were made from neurovascular bun-
dles isolated central to the inferior mesenteric ganglia. 
Signals were amplified at a gain of 5  K, band pass fil-
tered (100–1,300  Hz), digitally filtered for 50  Hz noise 
(Humbug, Quest Scientific, Canada), and data acquired at 
20 kHz (micro1401; Cambridge Electronic Design, UK). 
Ongoing nerve discharge was quantified from spikes 
passing a threshold level set at twice the background 
noise (typically ~100 μV). All signals were displayed on 
a PC using Spike 2 software. The baseline pressure was 
set up at 2–3 mmHg and recordings were maintained for 
approximately 30 min before initiating the experimental 
protocols.
Mechanosensitivity was evaluated using ramp and phasic 
distension protocols. For the ramp distension protocol the 
luminal outflow cannula was blocked and the subsequent in-
crease in pressure was observed until the desired maximum 
of 80 mmHg was reached (~2.5 min), at which point the lu-
minal outflow was re-opened. For the phasic distension pro-
tocol, a rapid increase in the intraluminal pressure from 0 to 
80 mmHg was achieved by switching the luminal outflow to 
a water column of sufficient height.
For drug treatments, two protocols were used. In one 
protocol three phasic distensions were performed to obtain 
a stable response to distension, and then galaninor vehicle 
(or the GalR1/2 agonists M617 and spexin, respectively, 
Tocris) was serosally superfused (20 ml volume) between 
the third and fourth phasic distension. In the second pro-
tocol the effect of galanin (or vehicle) was examined on 
ramp and phasic distension (an initial ramp distension fol-
lowed by three phasic distensions) in nonsensitized prepa-
rations (continual luminal perfusion with Krebs buffer) 
or sensitized preparations. Sensitization was achieved by 
intraluminal perfusion of an inflammatory soup that has 
previously been shown to increase resting afferent activity 
(Su & Gebhart 1998:10 μM histamine, 10 μM prostaglan-
din E2, 10 μM 5HT, 1 μM bradykinin, and 1 mM ATP) for 
20  min prior to and during subsequent ramp and phasic 
distensions.
2.3 | Analysis of electrophysiological  
recordings
Phasic distension of the colon by 80 mmHg leads to an in-
crease in LSN activity, which consists of an initial peak re-
sponse that reduces in magnitude to a sustained increase in 
nerve discharge for the remainder of the distension period. 
Nerve discharge returning to baseline levels following 
cessation of the phasic distension. Peak changes and time 
profiles of LSN activity were determined by subtracting 
baseline firing (average over 60 s before distension) from 
increases in LSN activity following distension. During 
phasic distensions, peak firing was defined as the maximal 
firing rate observed during distensions, occurring within 
the first 15 s, and sustained firing frequency was defined 
as the activity seen during the subsequent 45 s of the pha-
sic distension. Drug effect was determined by comparing 
an average of the first three distensions to the response of 
the third postdrug distension. By contrast, ramp distension 
leads to a slow and steady increase in activity until the end 
of the distension. Pressure profiles of LSN activity were 
determined by subtracting baseline firing from peak LSN 
activity measured every 5 mmHg.
2.4 | Retrograde labeling of colonic 
sensory neurones
Retrograde labeling of colonic sensory neurones was con-
ducted as previously described (Hockley et al., 2019). In 
brief, C57BL/6J mice were anesthetized with isoflurane 
(4% induction and 1%–2% maintenance) then a midline 
laparotomy (~1.5 cm incision) performed to reveal the dis-
tal colon. Five injections of 0.2-μL Fast Blue (2% in saline, 
Polysciences GmbH, Germany) were made into the wall of 
the distal colon using a glass needle at a rate of 0.4 μL/min 
using a microinfusion pump (Harvard Apparatus). After 
the abdominal cavity was flushed with saline to remove 
any excess Fast Blue dye, the muscle and skin layers were 
sutured and secured using 4–6 Michel clips. Postoperative 
care and analgesia (buprenorphine 0.05–0.1  mg/kg) were 
provided and a glucose-enriched soft diet provided, with 
regular checks of body weight. After 3–5 days, the animals 
were killed using sodium pentobarbital (200  mg/kg i.p.) 
and transcardially perfused with phosphate-buffered saline 
(PBS) followed by paraformaldehyde (4% in PBS; pH 7.4). 
Dorsal root ganglia (DRG; T13—L1) were removed and 
further fixed in 4% paraformaldehyde for 30  min at 4°C 
before cryoprotection in 30% sucrose overnight at 4°C. 
The tissue was then embedded in Shandon M-1 Embedding 
Matrix (Thermo Fisher Scientific), snap frozen in liquid ni-
trogen, and stored at −80°C until needed. Cryostat (Leica, 
CM3000; Nussloch) sections (12 μm) were collated across 
4 of 14 |   TAYLOR eT AL.
10 slides (Superfrost Plus, Thermo Fisher Scientific) for 
each DRG.
2.5 | Immunohistochemistry
DRG sections were washed with PBS (twice for 2 min) and 
then blocked using antibody diluent (10% donkey serum, 
5% bovine serum albumin, and 0.2% Triton X-100 in 0.1 M 
PBS) for 1 hr. This was followed by overnight incubation 
at 4°C with the appropriate primary antibodies (Table 1, 
we thank Prof. Theodorsson, Linköping University, for 
the kind gift of the anti-galanin antibody Theodorsson and 
Rugarn 2000). The sections were then washed three times 
for 5  min with PBS and then incubated for 2  hr at room 
temperature with the appropriate fluorophore-conjugated 
secondary antibodies (Table 2). No labeling was observed 
in control experiments where the primary antibody was ex-
cluded or in the presence of galanin as a blocking peptide 
for the anti-galanin antibody.
2.6 | Imaging and quantification
Sections were imaged using an Olympus microscope 
(BX51) with Qicam camera and the relative intensities 
of DRG neurones after immunostaining were measured 
(ImageJ 1.51n analysis software, NIH, USA). The mean 
background intensity was subtracted to control for vari-
ability in illumination between images. Percentages of 
relative intensities were determined by comparison with 
least intensely (0%) and the most intensely (100%) labeled 
cells for each section. Relative intensities are calculated 
by subtracting the relative intensity of the darkest neuronal 
profile (a) from the relative intensity of the cell of inter-
est (b) and comparing this to the relative intensity of the 
brightest neuronal profile (c) with the relative intensity of 
the darkest neuronal profile subtracted: relative cell inten-
sity = (b – a)/(c – a) (Fang et al., 2002); cells with intensity 
values greater than the mean intensity of the darkest neu-
ronal profiles from all the sections plus five times its stand-
ard deviation (SD) were considered positively labeled.
2.7 | Dextran sulfate sodium (DSS) model of 
induced colitis
C57BL/6J mice of either sex (8–12 weeks old) were weighed 
2 days prior to the procedure; weight and stool content/con-
sistency were then monitored daily throughout the treatment. 
Drinking water supplemented with 3% DSS (40,000  MW, 
Alfa Aesar) was administered with control mice receiving the 
same drinking water without DSS. The mice received DSS-
treated water for 5 days after which it was replaced with nor-
mal drinking water for a further 2 days. The experimenter was 
blinded, and solutions labeled A and B being unblinded after 
results were fully analyzed. Oral administration of DSS leads 
to weight loss, diarrhea, and blood in the stool, which was 
scored to produce a disease activity index (DAI) (Table 3) 
(Manicassamy & Manoharan, 2014). On day 7, mice were 
killed, and relevant tissue samples, Wallace macroscopic 
score (Table 4; Fang et al., 2002), and measurements were 
obtained. An approximate 1-cm section of colon was re-
moved about 4 cm from the anus and fixed in 4% paraformal-
dehyde for 4 hr and cryoprotected in 30% sucrose overnight. 
The tissue was then embedded in O.C.T mounting media 
(VWR Q-path Chemicals), snap frozen in liquid nitrogen, 
and stored at −80°C until needed.
T A B L E  1  List of primary antibodies
Primary antibody Conc. Company Catalogue # RRID References
Rabbit anti-galanin 1:1,000 Theodorrson Lab Kind gift – Sternini et al., 2004)
Guinea pig anti-TRPV1 1:1,000 Alomone Labs AGP-118 AB_2721813 Ritchie, 1973)
Goat anti-Gfrα3 1:300 R&D Systems AF2645 AB_2110295 Albers et al., 2014)
Goat anti-CGRP 1:500 Abcam AB36001 AB_725807 Branchek et al., 1998)
T A B L E  2  List of secondary antibodies
Secondary antibody Conc. Company Catalogue # RRID
Donkey anti-rabbit IgG-Alexafluor-488 1:1,000 Invitrogen A-21206 AB_2535792
Donkey anti-rabbit IgG-Alexafluor-568 1:1,000 Invitrogen A10042 AB_2534017
Donkey anti-goat IgG-Alexafluor-568 1:1,000 Invitrogen A-11057 AB_2534104
Donkey anti-guinea pig IgG-Alexafluor-488 1:1,000 Jackson Immuno Research 706-165-148 AB_2340460
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2.8 | Histology: H&E with alcian 
blue staining
Cryostat sections of colon (20 μm) were collected and stored 
at −20°C until needed. Slides were washed in tap water for 
2 min before staining for 5 min with hematoxylin (1:2 dilu-
tion with tap water; Sigma), washing in tap water for 3 min 
followed by 0.3% HCl in ethanol for 30 s, and then imme-
diately washing in tap water for a further 2 min before in-
cubating in tap water until the tissue developed a deep blue 
appearance. Slides were then stained with alcian blue (1% 
W/V in 3% acetic acid; Polysciences Inc) for 10  min and 
washed in tap water for 2  min before being immersed in 
100% ethanol for 30 s. Slides were then stained with eosin 
(Acros Organics) for 90 s, washed in tap water for 1 min, and 
then dehydrated in 100% ethanol for 30 s followed by 70% 
ethanol for 30 s. Slides were then cleared using Histoclear 
(National Diagnostics) for 30 s before mounting coverslips 
with Mowiol mounting media. Imaging was carried out using 
a NanoZoomer S60 Digital slide scanner. A histopathologi-
cal score was made based on presence of inflammatory cells, 
crypt damage, and ulceration, visualized using H&E stain-
ing, and alcian blue to stain the goblet cells in the crypts 
(Table 5).
2.9 | Biotinylated hyaluronan binding 
protein (HABP) staining
Twenty- micrometer colon sections were cut using a cry-
ostat and mounted on glass slides, which were washed 
twice with PBS-Tween before being blocked with an an-
tibody diluent solution (0.2% Triton X-100 and 5% bo-
vine serum albumin in PBS) for 1 hr at room temperature. 
Slides were incubated in biotinylated hyaluronan binding 
protein (Amsbio, 1:200) at 4°C overnight and then washed 
three times in PBS-Tween and incubated for 2 hr at room 
temperature with Alexafluor 488 conjugated streptavidin 
(Invitrogen, 1:1,000). Slides are then washed three more 
T A B L E  3  Disease activity index (DAI)
Score Weight loss Stool consistency Blood in stool
0 None Normal Normal
1 1%–5%
2 5%–10% Very Soft Slight bleeding
3 10%–15%
4 ≥15% Watery diarrhea Gross bleeding
Note: Scoring for all three criteria produces a maximal score of 12.
Score Criteria
0 No damage
1 Hyperemia, no ulcers
2 Hyperemia and thickening of bowel wall. No ulcers
3 One ulcer without thickening of the bowel wall
4 Two or more sites of ulceration and inflammation
5 Two or more major sites of ulceration/inflammation, or one site of ulceration/in-
flammation extending ≥1 cm
6–10 If damage covered ≥2 cm along the colon, the score was increased by 1 for each 
additional centimeter
T A B L E  4  Wallace macroscopic 
scoring
T A B L E  5  Histopathological assessment of colon sections
Score Inflammation Crypt damage Ulceration
0 None Crypts intact None
1 Increased number of granulocytes in lamina propria Loss of basal one third of crypt 1–2 foci of ulceration
2 Confluence of inflammatory cells extending to 
submucosa
Loss of basal two thirds of crypt 3–4 foci of ulceration
3 Transmural extent of infiltrate Entire crypt loss Confluent or extensive 
erosion
4 – Change in epithelial surface with 
erosion
–
5 – Confluent erosion –
Note: Scoring for all three criteria produces a maximum score of 11.
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times with PBS-Tween before being mounted and im-
aged using an Olympus BX51 microscope and QImaging 
camera.
2.10 | Statistics
All statistical analyses were performed using GraphPad 
Prism 6. IC50 values were derived by a sigmoidal dose–re-
sponse (variable slope) curve using GraphPad Prism soft-
ware. For ramp distensions, a repeated measures two-way 
ANOVA with Sidak's post hoc test was used. Both basal 
firing and phasic distension data were analyzed using a re-
peated measures one-way ANOVA with Tukey's post hoc 
test. For the validation of the DSS model, DSS data were 
compared to control data using Student's t test. Statistical 
significance was set at p  <  .05. Data are presented as 
mean ± SD, N = number of animals, and n = number of 
cells.
3 |  RESULTS
3.1 | Galanin suppresses mechanically 
evoked LSN firing
Single-cell RNA sequencing of colonic sensory neurones 
suggests that galanin is expressed in putative nociceptors 
(Hockley et al., 2019) and we confirmed this through im-
munohistochemistry on TL DRG from mice in which the 
distal colon had been injected with the retrograde tracer 
fast blue. Galanin labeled 22.7 ± 8.3% of colonic sensory 
neurones (N = 3, n = 466) and 4.5 ± 2.5% of all TL sensory 
neurones (N = 3, n = 1,516). When examining coexpres-
sion with Gfrα3, the expression of which correlates with 
Trpv1, a marker for high-threshold stretch-sensitive colo-
rectal afferents (Malin, Christianson, Bielefeldt, & Davis, 
2009), we observed marked colocalization between Gfrα3 
and galanin in colonic sensory neurones: Gfrα3 staining 
was present in 90.6 ± 1.2% of galanin-positive TL colonic 
sensory neurones (N  =  3, n  =  71, Figure 1a, left panel) 
compared with overall Gfrα3 expression of 43.3 ± 7.5% in 
TL colonic sensory neurones (N = 3, n = 407). Similarly, 
the nociceptive marker Trpv1 was also highly enriched in 
galanin-positive TL colonic sensory neurones (97 ± 2.5% 
N  =  3, n  =  48, Figure 1a, middle panel) compared with 
overall expression of 48.7 ± 3.3% (N = 3, n = 380) of TL 
colonic sensory neurones. Lastly, galanin was highly co-
expressed with the peptidergic neuronal marker CGRP in 
colonic sensory neurones: 86.5 ± 6.7% galanin-positive TL 
colonic sensory neurones (N = 3, n = 47, Figure 1a, right 
panel). These results align with RNA-sequencing data and 
confirm that galanin is highly expressed in nociceptive co-
lonic sensory neurones.
To determine the effect of galanin on LSN mechanosen-
sitivity, we measured the effects of 500 nM galanin on the 
response to a ramp distension of the colon (0–80 mmHg) and 
observed a robust inhibition of spike frequency across the 
pressure range used, an effect that was most pronounced at 
80 mmHg (Figure 1b and c). We therefore used a rapid pha-
sic distension of the colon to noxious pressure (80 mmHg) 
to investigate the dose-dependent effect of galanin upon 
LSN mechanosensitivity. Galanin inhibited LSN firing in a 
dose-dependent manner, with the response to galanin being 
most marked on the third phasic distension after galanin 
infusion (subsequent values are therefore taken from this 
third distension, Figure 1d). The maximal suppression of 
the peak afferent response to phasic colonic distension 
was observed following the application of 500 nM galanin 
which produced an approximate 50% reduction in afferent 
mechanosensitivity (53.3  ±  12.8 spikes/s vs. 25.2  ±  5.2 
spikes/s, N = 5, p < .0008, one-way ANOVA with Tukey's 
test) and the IC50 calculated from the data was 65.7  nM 
(Figure 1e). A similar suppression by 500 nM galanin was 
observed of the sustained firing that occurred during the 
last 45 s of the distension (24.5 ± 8.6 spikes/s vs. 9.3 ± 4.3 
spikes/s, N = 5, p = .013, unpaired t test).
3.2 | Galanin suppresses noxious 
mechanically evoked neuronal excitation 
via GalR1
Having determined that galanin suppressed colonic afferent 
mechanosensitivity we next investigated the effect of GalR1 
and GalR2 agonists on LSN activity. Using the same protocol 
F I G U R E  1  Galanin is expressed in colonic sensory neurones and inhibits LSN mechanosensitivity. (a) Galanin is expressed in TL colonic 
sensory afferents labeled with fast blue (FB) and is coexpressed with the nociceptive markers Gfrɑ3 (i) and Trpv1 (ii), and the peptidergic marker 
CGRP (iii); scale bar 50 µm. (b) Example raw trace of ramp distension and response showing inhibition of activity by galanin. (c) Galanin inhibits 
the LSN response to ramp distension over a wide range of pressure. Firing frequency calculated by subtraction average baseline firing 1 min 
before distension (two-way repeated-measures ANOVA with Sidak's post hoc test, N = 6). (d) Example raw trace and frequency histogram of the 
LSN response to repeated phasic intraluminal distension (0 to 80 mmHg), showing reversible inhibition by galanin. Below, expanded sections of 
basal activity before (left) and after (right) galanin application and a single action potential (black box). Blue boxes indicating distensions used for 
analysis. (e) Galanin dose dependently inhibited the peak response to phasic distension (one-way ANOVA with Tukey's test, N = 6 for 100 nM and 
N = 5 for all other groups). *p < .05, **p < .01, ***p < .001
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as for galanin, the selective GalR1 agonist M617 (500 nM) elic-
ited a reduction in LSN mechanosensitivity comparable in mag-
nitude to galanin at 500 nM, such that the peak LSN response 
to mechanical distension was suppressed from 77.4  ±  10.3 
spikes/s versus 46.5 ± 8.8 spikes/s (Figure 2a; p = .0015, N = 4, 
paired t test) and the sustained response was also suppressed 
from 37.3 ± 8.8 spikes/s versus 22.6 ± 6.9 spikes/s (Figure 2b; 
p = .038, N = 4, paired t test). The effect of 500-nM M617 was 
similar to that of 500 nM galanin: M671 attenuated peak firing 
frequency by 41.4 ± 7.5% and 500 nM galanin suppressed peak 
firing frequency by 49.3 ± 16.9% (M617 N = 4, galanin N = 5). 
By contrast, 1 µM of the endogenous GalR2 agonist spexin, 
which shows no binding to GalR1 (Kim et al., 2014), had no ef-
fect on LSN colonic afferent mechanosensitivity in response to 
phasic distension of the colon (Figure 2c and d). These results 
show that galanin acts via GalR1 to suppress LSN activity in 
response to distension of the colon.
3.3 | Galanin suppresses 
mechanical hypersensitivity induced by 
inflammatory mediators
We next investigated the effect of galanin on the sensitization 
of the LSN afferent response to colonic distension by intralu-
minal perfusion with an inflammatory soup (IS: ATP, hista-
mine, PGE2, bradykinin, and serotonin) (Hockley et al., 2014; 
Su & Gebhart, 1998). The IS was intraluminally perfused 
following the third phasic distension (either alone or with 
500 nM of galanin, Figure 3a–d). As expected, IS significantly 
increased the peak firing frequency in response to phasic dis-
tension (31.2  ±  28.1%, p  <  .05, N  =  6, one-way ANOVA 
with Tukey's test, Figure 3e), whereas coapplication of IS and 
galanin did not produce a significant change in peak afferent 
firing compared with control (Figure 3e). A similar effect was 
observed with regard to the sustained firing frequency, such 
that IS application significantly increased sustained firing fre-
quency (40.3 ± 26.7%, p < .05, N = 6, one-way ANOVA with 
Tukey's test), which was not observed when IS was combined 
with 500 nM galanin (Figure 3f). Lastly, we also observed 
that the basal LSN activity increased by 81.6 ± 19.3% fol-
lowing IS application (p < .01, N = 6, one-way ANOVA with 
Tukey's test), but that combination of IS and galanin did not 
significantly change the basal firing from the control group, 
suggesting that the effects of galanin and IS cancel each other 
out when coadministered (Figure 3e).
To further investigate LSN hypersensitivity caused by IS 
application and how this is affected by galanin, we used a 
ramp distention (0–80 mmHg over ~2.5 min). As expected, 
IS significantly increased activity across a broad range of 
pressures (Figure 3h, N = 6), and again the combination of IS 
and galanin resulted in a pressure-induced activity relation-
ship that was not significantly different from control (Figure 
3i, N = 6). These results demonstrate that galanin suppresses 
inflammatory mediator-induced mechanical hypersensitivity 
of LSN afferents in the colon.
F I G U R E  2  GalR1 activation 
suppresses LSN responses to phasic 
distension. (a) The GalR1 agonist M671 
significantly attenuates both LSN peak 
(p = .0015, N = 4, paired t test) and 
sustained (b; p = .0382, N = 4, paired t test) 
firing in response to phasic distension of the 
colon to 80 mmHg. (c) The GalR2 agonist 
Spexin does not significantly attenuate or 
excite the peak (c; p = .245, N = 4, paired 
t test) or sustained (d; p = .218, N = 4, 
paired t test) response to phasic distension 
of the colon to 80 mmHg. Firing frequency 
calculated by subtraction average baseline 
firing 1 min before distension. *p < .05, 
**p < .01
/
/ /
/
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3.4 | Galanin does not suppress DSS-
induced mechanical hypersensitivity
Using the DSS model of colitis, we observed that DSS-treated 
mice showed significant weight loss from day 4 onwards 
compared with untreated mice (e.g., on day 7, 82.1 ± 1.9% 
vs. 103.9 ± 3.6% of starting weight, N = 10, p < .0001, un-
paired t test) (Figure 4a), and also a significant increase in 
disease activity index (DAI, Figure 4b). Following dissec-
tion, colon length was observed to be significantly decreased 
(Figure 4c and d) and the colon wet weight to length ratio 
also significantly increased in DSS mice compared with 
the control group (Figure 4e). We observed both significant 
macroscopic and histological damage (Figure 4f–h) in colon 
sections from DSS mice compared with those from healthy 
mice, as well as significant thickening of the muscular layer 
of the colon in the DSS group (Figure 4i) as others have ob-
served (Marrero, Matkowskyj, Yung, Hecht, & Benya, 2000; 
Sánchez-Fidalgo, 2012). Lastly, the extracellular matrix 
polysaccharide hyaluronan (HA) was largely absent from the 
colon epithelium of DSS-treated mice (Figure 4j).
Using the DSS model, we investigated if the suppression 
of LSN activity by galanin in healthy mice (Figure 1) was 
maintained in LSN from mice undergoing DSS-induced co-
lonic inflammation. Using a ramp distention, we observed 
that the LSN isolated from DSS-treated mice produced a 
greater response at nonnociceptive pressure (20  mmHg, 
6.9 ± 5 spikes/s vs. 19.8 ± 4.7 spikes/s, p = .0184, N = 6, 
t test), but not at nociceptive pressure compared to the LSN 
from healthy mice (34.7 ± 8.1 spikes/s vs. 39.7 ± 3.2 spikes/s, 
p =  .137, N = 6, Student's t test; 80 mmHg, Figure 5a). In 
addition, the basal firing of LSN from DSS-treated mice 
was significantly greater than that of healthy mice (3.9 ± 1.4 
spikes/s vs. 28.4 ± 13.4 spikes/s, p = .012, N = 6, Student's t 
test). Together with the ramp distension response data, these 
results suggest that DSS induced a state of visceral hypersen-
sitivity at the level of the primary afferent. Whereas galanin 
was observed to significantly suppress the peak and sustained 
F I G U R E  3  Galanin suppresses the 
effects of IS on LSN mechanosensitivity. 
(a) Schematic of pressure protocol used in 
the multiunit recordings. Ramp and phasic 
distensions demonstrated below indicated 
with blue box, intraluminal application 
of drug indicated by black bar above the 
protocol. Example raw trace of ramp and 
phasic distension before and after the 
intraluminal application of inflammatory 
soup (b), a combination of Inflammatory 
soup and galanin (500 nM, c), and sample 
pressure distensions (d). Changes in peak 
(e), sustained (f), and basal (g) firing 
after intraluminal application of either 
inflammatory soup or a combination. 
Significant differences between groups 
tested by one-way ANOVA with Tukey's 
test, *p < .05, **p < .01 (N = 6). Response 
profiles to ramp distension before and 
during intraluminal application of 
inflammatory soup (h) or a combination 
of IS and galanin (i, two-way repeated-
measures ANOVA with Sidak's post hoc 
test, N = 6). Firing frequency calculated by 
subtraction average baseline firing 1 min 
before distension. Significance indicated by 
#p < .05, *p < .01, ~ p < .001
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/
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LSN responses induced by a phasic distension to 80 mmHg 
of the colon in healthy mice (Figure 1), no such suppressive 
effect was observed when measuring LSN activity in nerves 
isolated from DSS mice: peak firing frequency (65.7 ± 16.6 
spikes/s vs. 66.6 ± 22.3 spikes/s, p =  .81, N = 6, paired t 
test; Figure 5b) and sustained firing frequency (34.1 ± 9.9 
F I G U R E  4  DSS induces weight loss and macroscopic changes to colon histology. (a) Body weight of DSS-treated mice was significantly 
reduced compared to untreated controls (*p < .05, ***p < .001, N = 10, two-way repeated-measures ANOVA with Sidak's post hoc). (b) 
DAI significantly increases in colitis-induced mice (***p < .001, N = 10, two-way repeated-measures ANOVA with Sidak's post hoc test). 
DAI = disease activity index; assessment of inflammation by clinical parameters. (c) Photograph of healthy and colitis-induced colons from 
cecum (left side) to anus (right side). (d) Colon length is significantly reduced in DSS mice (p < .001, N = 10, paired t test). (e) Colon weight to 
length ratio significantly increased in DSS mice (p < .001, N = 10, paired t test). (f) Macroscopic score is based on visual assessment of ulceration 
and hyperemia of the colon (p < .001, N = 10, paired t test). (g) H&E with alcian blue staining of colonic tissue. In DSS mice, there was active 
inflammation, and crypt or surface epithelial damage compared to untreated controls. Areas defined by black boxes are magnified in the lower 
images; scale bar for top images is 1 mm and for bottom images 250 μm. (h) Histology score significantly increases in DSS mice (p < .001, N = 10, 
paired t test) and the colonic muscle layer becomes significantly thicker in DSS mice (i, p < .001, N = 10, paired t test). (j) Changes in hyaluronic 
acid binding protein (HABP; green) arrangement and distribution in colitis-induced and healthy colons
/
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spikes/s vs. 41.9 ± 14 spikes/s, p = .54, N = 6, paired t test; 
Figure 5c) induced by a phasic distension to 80 mmHg were 
affected by administration of galanin. These results indicate 
that the suppressive action of galanin is lost in tissue isolated 
from mice with acute colitis.
4 |  DISCUSSION
Our data demonstrate that galanin suppresses LSN re-
sponses to noxious mechanical stimuli and the sensitiza-
tion of colonic mechanosensitivity by acute application of 
inflammatory mediators. This suppressive effect of galanin 
was not seen in tissue isolated from mice with colitis. Our 
data further suggest that GalR1 mediates the suppressive 
effect of galanin. These data fit alongside galanin's re-
ported function in the upper GI tract (Page et al., 2005) and 
parallels with the function of galanin in somatic sensory in-
nervation (Flatters, Fox, & Dickenson, 2003; Heppelmann, 
Just, & Pawlak, 2000).
Galanin is expressed by multiple cell types in the dis-
tal colon including enterochromaffin cells and fibroblasts 
(Schäfermeyer et al., 2004; Yamamoto, Iguchi, Unno, 
Kaji, & Hoshino, 2014), and, as we show here, a subset 
of colonic sensory neurones also express galanin. Galanin 
has been implicated as a modulator of numerous activities 
in the GI tract including regulation of neurotransmitter re-
lease, motility, and secretion (Benya, Marrero, Ostrovskiy, 
Koutsouris, & Hecht, 1999; Sternini et al., 2004). With 
regard to the transmission of sensory information from 
the GI tract, galanin has been shown to modulate mech-
anosensitivity of gastrooesophageal vagal afferents with 
predominantly suppressive actions on individual fibers via 
GalR1 (Page et al., 2007, 2005). Our data build on this 
by demonstrating that galanin suppresses LSN mechano-
sensitivity and likely does so though GalR1 activation on 
LSN afferents. Another possibility to consider is that the 
effects of galanin occur via secondary actions resulting 
from paracrine signals from nonneuronal calls. In inflam-
mation, mediators released from activated enteric mast 
cells have the potential to sensitize colonic afferents to be-
come hyperexcitability to stimuli such as colonic disten-
sion (Wang et al., 2014; Wood, 2011). Galanin is known 
to suppress paracrine signal transmission in the gut (Liu, 
2003; Tamura, Palmer, & Wood, 1987) and with GalR ex-
pression being found in immune cells in the colon could 
suggest that galanin release suppresses neurotransmis-
sion from afferents to mast cells and suppresses release 
of sensitizing mediators from the mast cells themselves. 
Mechanical distension of the colon is capable of pro-
ducing pain in humans and nociceptive behavior in ani-
mals (Gebhart, 2004; Ness, Metcalf, & Gebhart, 1990). 
Consequently, distension is a useful tool when defining 
noxious responses in afferent preparations and examining 
hyperexcitability to colonic inflammation. We find from 
multiunit recordings of LSN activity that galanin sup-
presses mechanically evoked responses to distension of the 
distal colon to noxious pressures, and the sensitization of 
these responses following addition of inflammatory stim-
uli. This suggests that galanin receptors, specifically in 
the case of the LSN GalR1, function as integral regulators 
of neuronal excitability. Multiple populations of sensory 
afferents innervate the distal colon with differing sensi-
tivities to mechanical stimuli (e.g., stretch, stroke, and 
von Frey hair probing of their receptive fields) (Brierley 
et al., 2004) and while we did not seek to characterize 
these groups more specifically, we did observe suppres-
sive effects of galanin across the full range of distension 
pressures from physiological through to noxious (i.e., 
0–80 mmHg, Figure 1c). When examining the expression 
of galanin, both colonic sensory neurone RNA sequencing 
and immunohistochemistry (Figure 1a) demonstrate that 
galanin is expressed in putative nociceptors in healthy ani-
mals (Hockley et al., 2019). With regard to GalR1, colonic 
sensory neurone RNA sequencing indicates that it is pre-
dominantly expressed in neurones expressing nociceptor 
F I G U R E  5  Galanin does not suppress DSS-induced LSN hypersensitivity. (a) DSS increases the response to nonnoxious (20 mmHg) but not 
noxious (80 mmHg) pressures using a ramp distension protocol; Student's t test between groups *p < .05. Galanin of 500 nM does not inhibit peak 
(b) or sustained (c) responses to phasic distension of the colon to 80 mmHg in colons isolated from DSS-treated mice (paired t test, N = 6). Firing 
frequency calculated by subtraction average baseline firing 1 min before distension
/ / /
a b c
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markers, such as Trpv1 and Gfrα3, as well as in a pop-
ulation of neurones expressing the mechanosensitive ion 
channel Piezo2, an expression pattern that likely explains 
the suppressive impact of galanin on LSN activity across 
a wide range of pressures (Figure 1c). The GalR1 receptor 
is coupled to G protein-coupled inwardly rectifying potas-
sium channels (GIRKs) giving rise to hyperpolarization 
(Smith et al., 1998; Walker et al., 1997), an effect that 
would account for the suppressive activity of galanin ob-
served in this study. This conclusion is further supported 
by data demonstrating that suppression of LSN activity 
was also produced by the GalR1 agonist M617, but not the 
GalR2 agonist spexin (Figure 2).
As observed in previous studies (Su & Gebhart, 1998), 
we found that intraluminal application of IS produced robust 
LSN hyperexcitability to mechanical stimuli (Figure 3). Part 
of this hyperexcitability likely results from recruitment of ‘si-
lent’ or mechanically insensitive afferents in both the LSN 
and PN (Feng & Gebhart, 2011), potentially through disinhi-
bition of Piezo2 (Prato et al., 2017). The ability of galanin to 
reverse the mechanically hypersensitivity induced by the IS 
correlates with the fact that a variety of inflammatory media-
tor receptors are present in colonic sensory neurones that also 
express GalR1 (Hockley et al., 2019). However, by contrast, 
galanin was not able to reduce the mechanical hypersensitiv-
ity present in LSN isolated from mice treated with DSS to 
induce a state of colitis.
Why is it that galanin counteracts the acute effects of 
inflammatory mediators on LSN activity, but has no such 
effect on LSN activity in a mouse model of colitis? It has 
been observed that galanin receptor expression is altered 
in certain models of inflammation and hence differential 
receptor expression could lead to galanin no longer exert-
ing a suppressive effect. For example, following hind-paw 
injection of carrageenan in rats, GalR1 mRNA expression 
in DRG neurones (L4 and L5) decreases (Xu, Shi, Landry, 
& Hökfelt, 1996) and a similar decrease in GalR1 expres-
sion could occur in the DSS model and hence galanin is no 
longer able to suppress mechanically evoked LSN activity; 
alternatively, there could be an increase in the expression of 
excitatory GalR2. The absence of reliable tools to investi-
gate GalR protein levels and the validity of current antibod-
ies being uncertain (Lu & Bartfai, 2009) make quantifying 
the protein level of GalRs in colonic afferents a significant 
challenge. However, there are also alternative explanations 
for the lack of measurable galanin activity. For example, 
multiple inflammatory mediators are released from in-
flamed colon tissue (Spiller & Major, 2016), which would 
act upon a broad range of afferents to induce a variety of 
transcriptional changes and posttranslational modifications, 
that is, both GalR1+ve and GalR1-ve afferents, and thus 
the mechanical hypersensitivity observed in LSN isolated 
from DSS-treated mice is likely at least partially mediated 
via GalR1-ve afferents. Therefore, any effect of galanin on 
the whole-nerve response may simply be overcome by the 
overall level of sensitization. A further explanation would be 
that the coupling of GalR1 is altered in inflammation due to 
altered expression of G proteins and/or that the signaling of 
galanin at GalR1 becomes biased toward different pathways. 
Further studies examining the effects of galanin on LSN hy-
persensitivity in other models of visceral pain (e.g., colonic 
instillation of trinitrobenzenesulfonic acid) would also be 
beneficial to determine if the loss of galanin's suppressive 
effect is common to animal models, which would lend fur-
ther insight for potential translation.
In conclusion, we have shown an unreported role for gal-
anin in the modulation of LSN function in the distal colon: 
galanin suppresses LSN mechanosensitivity and acute me-
chanical hypersensitivity induced by an IS. Future work 
should elucidate mechanisms underpinning why galanin is 
unable to exert any suppression on LSN mechanical hyper-
sensitivity following prolonged (in vivo) inflammation.
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